Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Division of Sleep Medicine, Harvard Medical School, Boston, MA 02115, USA.
J Clin Endocrinol Metab. 2024 May 17;109(6):e1434-e1441. doi: 10.1210/clinem/dgad731.
Psychological distress has been linked to diabetes risk. Few population-based, epidemiologic studies have investigated the potential molecular mechanisms (eg, metabolic dysregulation) underlying this association.
To evaluate the association between a metabolomic signature for psychological distress and diabetes risk.
We conducted a nested case-control study of plasma metabolomics and diabetes risk in the Nurses' Health Study, including 728 women (mean age: 55.2 years) with incident diabetes and 728 matched controls. Blood samples were collected between 1989 and 1990 and incident diabetes was diagnosed between 1992 and 2008. Based on our prior work, we calculated a weighted plasma metabolite-based distress score (MDS) comprised of 19 metabolites. We used conditional logistic regression accounting for matching factors and other diabetes risk factors to estimate odds ratios (OR) and 95% confidence intervals (CI) for diabetes risk according to MDS.
After adjusting for sociodemographic factors, family history of diabetes, and health behaviors, the OR (95% CI) for diabetes risk across quintiles of the MDS was 1.00 (reference) for Q1, 1.16 (0.77, 1.73) for Q2, 1.30 (0.88, 1.91) for Q3, 1.99 (1.36, 2.92) for Q4, and 2.47 (1.66, 3.67) for Q5. Each SD increase in MDS was associated with 36% higher diabetes risk (95% CI: 1.21, 1.54; P-trend <.0001). This association was moderately attenuated after additional adjustment for body mass index (comparable OR: 1.17; 95% CI: 1.02, 1.35; P-trend = .02). The MDS explained 17.6% of the association between self-reported psychological distress (defined as presence of depression or anxiety symptoms) and diabetes risk (P = .04).
MDS was significantly associated with diabetes risk in women. These results suggest that differences in multiple lipid and amino acid metabolites may underlie the observed association between psychological distress and diabetes risk.
心理困扰与糖尿病风险有关。很少有基于人群的、流行病学研究调查了这种关联的潜在分子机制(例如,代谢失调)。
评估心理困扰的代谢组学特征与糖尿病风险之间的关联。
我们对护士健康研究中的血浆代谢组学和糖尿病风险进行了嵌套病例对照研究,包括 728 名(平均年龄:55.2 岁)发生糖尿病的女性和 728 名匹配的对照者。血液样本采集于 1989 年至 1990 年之间,1992 年至 2008 年期间确诊为糖尿病。基于我们之前的工作,我们计算了一个由 19 种代谢物组成的加权血浆代谢物为基础的应激评分(MDS)。我们使用条件逻辑回归,考虑到匹配因素和其他糖尿病风险因素,根据 MDS 评估糖尿病风险的比值比(OR)和 95%置信区间(CI)。
在调整了社会人口因素、糖尿病家族史和健康行为因素后,MDS 五分位数的 OR(95%CI)在 Q1 为 1.00(参考),Q2 为 1.16(0.77,1.73),Q3 为 1.30(0.88,1.91),Q4 为 1.99(1.36,2.92),Q5 为 2.47(1.66,3.67)。MDS 每增加一个标准差,糖尿病风险就会增加 36%(95%CI:1.21,1.54;P 趋势 <0.0001)。这种关联在进一步调整体重指数后适度减弱(可比 OR:1.17;95%CI:1.02,1.35;P 趋势 =0.02)。MDS 解释了自我报告的心理困扰(定义为存在抑郁或焦虑症状)与糖尿病风险之间关联的 17.6%(P=0.04)。
MDS 与女性的糖尿病风险显著相关。这些结果表明,多种脂质和氨基酸代谢物的差异可能是心理困扰与糖尿病风险之间观察到的关联的基础。